Shrivastav Sandhya, Mittal Sneha, Sharma Sunita, Kumar Amit
Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation, Maharishi Markandeshwar (deemed to be) University, Mullana-Ambala, India.
Pain Manag. 2025 Aug;15(8):509-517. doi: 10.1080/17581869.2025.2527616. Epub 2025 Jul 12.
The study aimed to investigate the effects of Temporoparietal Fascia trigger point release in subjects with Tension Type Headache (TTH) and on decreasing pain intensity and head and neck disability.
40 subjects were randomly assigned to either Group 1 (intervention group) or Group 2 (control group) and received treatment for 10 days. Outcome measures, including the Visual Analog Scale (VAS) for pain intensity, Neck Disability Index (NDI) for neck disability, Headache Disability Inventory (HDI) for headache disability, and Pressure Pain Threshold (PPT) were used. Assessments were conducted in both groups before and after the 10-day intervention period.
Both groups exhibited statistically significant improvements in pain intensity, neck and headache disability, and pressure pain threshold after 10 days of intervention ( = 0.001). However, the intervention group showed greater clinical improvement compared to the control group. Between-group analysis revealed significant differences favoring the intervention group in VAS ( = 10.63), NDI ( = 7.81), HDI ( = 8.00), and PPT ( = 2.60), indicating that trigger point release in the temporo-parietal fascia was more effective in reducing symptoms and enhancing pain threshold.
The study concluded that Myofascial trigger points (MTrPs) release is notably effective in pain reduction, as evidenced by greater clinical improvement in the intervention group compared to the control group. Both groups experienced similar benefits in reducing head and neck-related disabilities and increasing pain pressure thresholds.
www.ctri.nic.in, identifier: CTRI/2023/06/054085.
本研究旨在探讨颞顶筋膜触发点释放对紧张型头痛(TTH)患者的影响,以及对降低疼痛强度和减轻头颈部功能障碍的作用。
40名受试者被随机分为第1组(干预组)或第2组(对照组),并接受为期10天的治疗。采用了包括疼痛强度视觉模拟量表(VAS)、颈部功能障碍指数(NDI)、头痛功能障碍量表(HDI)和压痛阈值(PPT)等结局指标。在为期10天的干预期前后,对两组进行了评估。
干预10天后,两组在疼痛强度、颈部和头痛功能障碍以及压痛阈值方面均表现出统计学上的显著改善(P = 0.001)。然而,与对照组相比,干预组显示出更大的临床改善。组间分析显示,干预组在VAS(P = 10.63)、NDI(P = 7.81)、HDI(P = 8.00)和PPT(P = 2.60)方面有显著差异,表明颞顶筋膜触发点释放对减轻症状和提高疼痛阈值更有效。
该研究得出结论,肌筋膜触发点(MTrPs)释放对减轻疼痛非常有效,干预组比对照组有更大的临床改善证明了这一点。两组在减轻头颈部相关功能障碍和提高疼痛压力阈值方面都有类似的益处。